차이나파마홀딩스 (CPHI) 주가

차이나파마홀딩스(CPHI)는 NYSE MKT에 상장된 Healthcare · Drug Manufacturers - Specialty & Generic 기업입니다. 현재가 $1.13 (+3.67%), 시가총액 $0.03B, 52주 범위 $0.52 ~ $2.22.

China Pharma Holdings, Inc. develops, manufactures, and markets pharmaceutical products for human use in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate injection to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Ozagrel Sodium to treat acute thrombotic cerebral infarction and dyskinesia; Alginic Sodium Dies

핵심 지표

• 현재가: $1.13 (+3.67%)
• 시가총액: $0.03B
• 52주 최저~최고: $0.52 ~ $2.22
• 섹터: Healthcare
• 산업: Drug Manufacturers - Specialty & Generic
• 거래소: NYSE MKT

차이나파마홀딩스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackQuant에서 실시간으로 확인할 수 있습니다.

차이나파마홀딩스 재무 요약

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 0.83
• 순이익률: -0.77%
• 영업이익률: -0.98%

자주 묻는 질문